GlassScriptPhysician profile
Sara A Berg
NPI 1417941006
$1,012.39
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $174 · 2021: $97.49 · 2022: $102.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $420.02 | 2019 | |
| Abbvie INC. | $202.42 | 2019-2021 | |
| Therapeuticsmd, INC. | $96.64 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $74.24 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $60.38 | 2019 | |
| Innovation Technologies INC | $45.30 | 2020 | |
| Organon LLC | $43.03 | 2022 | |
| Ethicon US, LLC | $21.78 | 2021 | |
| Agile Therapeutics, INC. | $18.19 | 2022 | |
| Avanos Medical | $17.99 | 2019 | |
| Coopersurgical, INC. | $12.40 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.